drugset / Trial / NCT06679413

A Study to Assess Drug-drug Interaction of ZX008 in Healthy Male and Female Study Participants

NCT06679413

Phase 1 Completed 22 enrolled UCB BIOSCIENCES, Inc.
NaSingle-groupOpen-labelBasic science

Summary

The purpose of the study is to assess the single-dose pharmacokinetics (PK) of 3 probe drugs (midazolam, bupropion, and metformin) before and after repeat doses of ZX008

Timeline

Start
2024-12-04
Primary completion
2025-06-12
Completion
2025-06-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupropion Small molecule Oral
Subject Metformin Small molecule Oral
Subject Midazolam Small molecule Oral
Background Fenfluramine Small molecule Oral

Indications

No indication recorded.